Market Overview - A total of 64 stocks in the A-share market hit the daily limit, with 57 stocks remaining after excluding 7 ST stocks, resulting in a limit-up rate of 79.01% [1] Stock Performance - The highest limit-up stock by order volume was Yingli Automotive with 385,100 hands, followed by Annie Co., Intercontinental Oil & Gas, and GCL-Poly Energy with 326,500 hands, 325,400 hands, and 310,400 hands respectively [2] - In terms of consecutive limit-up days, Beikong Technology achieved 5 consecutive limit-ups, while Yingli Automotive and Huayang New Materials had 3 consecutive limit-ups [2] Investment Highlights - GCL-Poly Energy announced a collaboration with Ant Group to issue the first and largest photovoltaic green asset RWA (Real World Asset) in December 2024, indicating strong investment returns based on the calculated IRR [2] - The oil and petrochemical sector saw multiple stocks limit-up, including Zhun Oil Co., Beiken Energy, Tongyuan Petroleum, and Heshun Petroleum, driven by a significant rise in international oil prices, which increased over 10% [3] - Beiken Energy made breakthroughs in overseas upstream business, acquiring 10 oil and gas rights in Canada, covering an area of 1,510.038 hectares [3] Nuclear Pollution Prevention - Stocks such as Huashengchang, Jieqiang Equipment, and China General Nuclear Power Technology saw limit-ups due to news of explosions at Iran's Natanz nuclear facility [4][5] - Huashengchang focuses on safety protection products for the petrochemical industry, while Jieqiang Equipment specializes in nuclear and biochemical safety [4] Military Industry - Stocks like Beifang Changlong, Chenxi Aviation, and Jieqiang Equipment experienced limit-ups, with Beifang Changlong primarily producing military drones [6] - Chenxi Aviation's products and services are involved in military and civilian applications, including aviation navigation and drone technology [6] Institutional Activity - New Jin Power saw net purchases exceeding 45 million yuan from institutions, with other notable stocks including Rongfa Nuclear Power and Hengbao Co. appearing on the leaderboard [7][8] - The top net purchases by institutions included Hainengda, Chenxi Aviation, and Tongyuan Petroleum, with amounts of 324 million yuan, 151 million yuan, and 128 million yuan respectively [8]

中新网衡阳6月11日电 题：湘江畔的"青春梦工厂"：看大学生如何把创意"酿"成现实 作者 胡雨桐 从核辐射探测机器人的精密调试、到古籍中萃取出的抗真菌新药雏形、再到国潮文创IP的绚丽绽放…… 在位于湖南衡阳的南华大学，一群年轻人正以知识为曲、以实践为缸，在湘江之畔这座无形的"青春梦 工厂"里，将奇思妙想"酿"成改变世界的力量。 游琼宇向 安全工程领域的专家介绍电离辐射实验教学平台。王祥帅 摄 资金"活水"浇灌硬核科技 走进南华大学核安全探测技术研究小组实验室，一台无人探测机器人正在进行调试。"它能代替人进入 高危区域进行核设施日常巡检，关键性能指标超过了国际同类产品。"南华大学2022级安全工程专业学 生、核安全探测技术研究小组负责人游琼宇介绍说。 然而，实验室数据和实际应用完全是两回事。团队在这方面曾遭遇严峻挑战——真实核辐射环境下，设 备甄别率大幅下降。 "理想与现实的鸿沟，几乎让我们寸步难行。"游琼宇坦言。就在团队在技术泥淖中艰难跋涉之际，学校 创新创业基金池中涌出的20万元专项资金，如同一场及时雨，为困顿的探索注入了生机。这笔来自学校 5000万元大学生创新创业基金池的"活水"，让大量昂贵的真实环境测 ...

Financial Data and Key Metrics Changes - The company reported $29 million of adjusted free cash flow, representing a 62% conversion of adjusted EBITDA [6] - First quarter orders grew by 11.5%, primarily driven by nuclear power orders, marking the best first quarter performance since going public [6][10] - Adjusted EBITDA totaled $47 million, an 18.2% increase year-over-year, with margins improving by 260 basis points to 23.1% [8][23] - Adjusted EPS increased by 67% to $0.10 per share compared to $0.06 in Q1 2024 [9][24] Business Line Data and Key Metrics Changes - Organic revenue grew by 6% year-over-year, with significant contributions from the nuclear power end market [8][22] - The Nuclear Safety segment saw first quarter revenue of $133.4 million, a 6% increase, with organic revenue up 7.6% [24] - The Medical segment reported first quarter revenue of $68.6 million, a 2.7% increase, with organic revenue growth of 3% [27][29] Market Data and Key Metrics Changes - The nuclear power market is expected to see high single-digit growth for the full year, driven by the existing installed base [25][70] - The company noted that 79% of the year-over-year nuclear power order growth came from the existing nuclear fleet [15][66] - The 2024 National Nuclear Energy Public Opinion Survey indicated that over 75% of Americans support the use of nuclear energy, reflecting growing public and political support [12] Company Strategy and Development Direction - The company aims for adjusted EBITDA margins of 30% by 2028, supported by operating leverage and procurement savings [8][15] - The acquisition of OncoSpace, a cloud-native data analytics platform, is expected to enhance the company's cancer care portfolio and go-to-market strategy [6][7] - The company is maintaining a disciplined approach to M&A activity amid uncertain market dynamics [7][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the prospects for large one-time opportunities in the pipeline, estimated at $300 to $400 million [10][20] - The company is well-positioned to navigate the current economic environment, with over 70% of revenue being recurring or repeat in nature [14][19] - Management reaffirmed full-year guidance for organic revenue growth, adjusted EBITDA, adjusted EPS, and adjusted free cash flow [20][32] Other Important Information - The company repurchased 1.2 million shares for $18.6 million as part of its capital deployment strategy [9][31] - The expected tariff exposure for 2025 is estimated to be between $3 million tailwind and $8 million headwind, with mitigating actions in place [19][20] Q&A Session Summary Question: Can you elaborate on the situation in China regarding tariffs? - Management indicated that most exposure comes from medical equipment produced in the U.S. and that there is potential for some products to be exempt from retaliatory tariffs [38] Question: What is the timeline for the $300 to $400 million pipeline? - Management expects a majority of contracts to be awarded within 2025, with projects being larger than typical flow business [47] Question: How is the company positioned regarding pricing power? - Management believes that competitive advantages may strengthen due to anticipated long-term tariff scenarios, potentially enhancing pricing power [78]